Emerging Implant Technologies (EIT) received FDA 510(k) clearance for 3D-printed spinal interbody devices to address anterior, transforaminal and posterior lumbar interbody fusion and cervical procedures.
The implants are manufactured from EIT Cellular Titanium® that yields a porosity of 80% and is designed to address clinical shortcomings such as non-fusion, biocompatibility, subsidence, migration and imaging distortion.
EIT is based in Germany. Since 2014, >10,000 cases have been performed with its products around the world.
Emerging Implant Technologies (EIT) received FDA 510(k) clearance for 3D-printed spinal interbody devices to address anterior, transforaminal and posterior lumbar interbody fusion and cervical procedures.
The implants are manufactured from EIT Cellular Titanium® that yields a porosity of 80% and is designed to address clinical shortcomings...
Emerging Implant Technologies (EIT) received FDA 510(k) clearance for 3D-printed spinal interbody devices to address anterior, transforaminal and posterior lumbar interbody fusion and cervical procedures.
The implants are manufactured from EIT Cellular Titanium® that yields a porosity of 80% and is designed to address clinical shortcomings such as non-fusion, biocompatibility, subsidence, migration and imaging distortion.
EIT is based in Germany. Since 2014, >10,000 cases have been performed with its products around the world.
Copy to clipboard 
